Galapagos NV ADR (GLPG)vsInsmed Inc (INSM)
GLPG
Galapagos NV ADR
$30.64
+2.82%
HEALTHCARE · Cap: $2.26B
INSM
Insmed Inc
$148.31
+6.59%
HEALTHCARE · Cap: $29.99B
Smart Verdict
WallStSmart Research — data-driven comparison
Insmed Inc generates 111% more annual revenue ($606.42M vs $286.92M). GLPG leads profitability with a -1.5% profit margin vs -2.1%. GLPG earns a higher WallStSmart Score of 47/100 (D+).
GLPG
Hold47
out of 100
Grade: D+
INSM
Hold39
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Earnings expanding 74.8% YoY
18.9% revenue growth
No standout strengths identified
Areas to Watch
ROE of -16.7% — below average capital efficiency
Negative free cash flow — burning cash
Currently unprofitable
Operating margin of -58.6%
1.5% revenue growth
0.0% earnings growth
Trading at 43.0x book value
ROE of -2.5% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : GLPG
The strongest argument for GLPG centers on Price/Book, EPS Growth, Revenue Growth. Revenue growth of 18.9% demonstrates continued momentum.
Bull Case : INSM
PEG of 1.09 suggests the stock is reasonably priced for its growth.
Bear Case : GLPG
The primary concerns for GLPG are Return on Equity, Free Cash Flow, Profit Margin.
Bear Case : INSM
The primary concerns for INSM are Revenue Growth, EPS Growth, Price/Book.
Key Dynamics to Monitor
GLPG profiles as a growth stock while INSM is a turnaround play — different risk/reward profiles.
INSM carries more volatility with a beta of 1.17 — expect wider price swings.
GLPG is growing revenue faster at 18.9% — sustainability is the question.
GLPG generates stronger free cash flow (-43M), providing more financial flexibility.
Bottom Line
GLPG scores higher overall (47/100 vs 39/100) and 18.9% revenue growth. Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Galapagos NV ADR
HEALTHCARE · BIOTECHNOLOGY · USA
Galapagos NV, a clinical-stage biotechnology company, discovers, develops and markets several small molecule drugs. The company is headquartered in Mechelen, Belgium.
Insmed Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Insmed Incorporated, a biopharmaceutical company, develops and markets therapies for patients with rare and serious diseases. The company is headquartered in Bridgewater, New Jersey.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?